What causes elevated direct bilirubin?

Elevated direct bilirubin typically indicates liver dysfunction or bile duct obstruction, with causes ranging from hepatitis and cirrhosis to gallstones and medications. Testing your liver function biomarkers can help identify the underlying cause and guide appropriate treatment.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Direct Bilirubin and Its Role in Your Body

Direct bilirubin, also known as conjugated bilirubin, is a water-soluble form of bilirubin that your liver produces as part of the normal breakdown of red blood cells. When old red blood cells are broken down, they release hemoglobin, which is converted to unconjugated (indirect) bilirubin. Your liver then processes this indirect bilirubin by adding glucuronic acid, creating direct bilirubin that can be easily excreted through bile into your intestines.

Normal direct bilirubin levels typically range from 0.0 to 0.3 mg/dL, representing about 20% of your total bilirubin. When these levels rise above normal, it often signals a problem with your liver's ability to process and excrete bilirubin properly, or an obstruction preventing bile from flowing normally. Understanding your bilirubin levels through comprehensive testing can provide crucial insights into your liver health and overall metabolic function.

The Difference Between Direct and Indirect Bilirubin

While both forms of bilirubin come from the breakdown of red blood cells, they behave differently in your body. Indirect bilirubin is fat-soluble and must be transported to the liver bound to albumin. Direct bilirubin, having been processed by the liver, is water-soluble and can be excreted in urine when levels become elevated. This distinction is crucial for diagnosing the underlying cause of jaundice and other liver-related conditions.

Direct Bilirubin Levels and Associated Symptoms

Symptoms typically appear when direct bilirubin exceeds 1.0 mg/dL, with jaundice visible when total bilirubin exceeds 2.5-3.0 mg/dL.
Direct Bilirubin LevelSeverityCommon SymptomsClinical Significance
0.0-0.3 mg/dL0.0-0.3 mg/dLNormalNoneHealthy liver function
0.4-1.0 mg/dL0.4-1.0 mg/dLMild elevationUsually asymptomaticEarly liver dysfunction or mild obstruction
1.1-3.0 mg/dL1.1-3.0 mg/dLModerate elevationMild jaundice, dark urine, fatigueSignificant liver disease or partial obstruction
>3.0 mg/dL>3.0 mg/dLSevere elevationObvious jaundice, itching, pale stoolsSevere liver disease or complete obstruction

Symptoms typically appear when direct bilirubin exceeds 1.0 mg/dL, with jaundice visible when total bilirubin exceeds 2.5-3.0 mg/dL.

Common Causes of Elevated Direct Bilirubin

Elevated direct bilirubin levels can result from various conditions affecting your liver, bile ducts, or both. Understanding these causes helps healthcare providers determine the most appropriate diagnostic tests and treatment approaches.

Liver Disease and Hepatitis

Liver diseases are among the most common causes of elevated direct bilirubin. Viral hepatitis (A, B, C, D, and E) can cause acute or chronic liver inflammation, impairing the liver's ability to process and excrete bilirubin. Alcoholic liver disease, ranging from fatty liver to cirrhosis, progressively damages liver cells and disrupts normal bilirubin metabolism. Non-alcoholic fatty liver disease (NAFLD), increasingly common in people with metabolic syndrome, can also lead to elevated direct bilirubin as liver function deteriorates.

Autoimmune hepatitis, where your immune system attacks liver cells, and genetic conditions like Wilson's disease (copper accumulation) or hemochromatosis (iron overload) can also cause chronic liver damage and elevated direct bilirubin levels.

Bile Duct Obstruction

When bile cannot flow normally from the liver to the intestines, direct bilirubin backs up into the bloodstream. Common causes of bile duct obstruction include:

  • Gallstones blocking the common bile duct (choledocholithiasis)
  • Pancreatic tumors compressing the bile duct
  • Bile duct strictures from inflammation or previous surgery
  • Primary biliary cholangitis (PBC), an autoimmune condition affecting small bile ducts
  • Primary sclerosing cholangitis (PSC), causing inflammation and scarring of bile ducts
  • Cholangiocarcinoma (bile duct cancer)

Medications and Toxins

Numerous medications can cause drug-induced liver injury, leading to elevated direct bilirubin. Common culprits include acetaminophen (especially in overdose), certain antibiotics (like amoxicillin-clavulanate), statins, anti-seizure medications, and some herbal supplements. Industrial toxins, mushroom poisoning, and excessive alcohol consumption can also cause acute liver damage with elevated direct bilirubin.

Symptoms Associated with High Direct Bilirubin

Elevated direct bilirubin often presents with characteristic symptoms that can help identify liver or bile duct problems. The severity of symptoms typically correlates with how high the bilirubin levels are and how quickly they rose.

Jaundice, the yellowing of skin and eyes, is the most recognizable sign of elevated bilirubin. With high direct bilirubin, you may also notice dark, tea-colored urine (due to water-soluble bilirubin being excreted) and pale, clay-colored stools (from lack of bilirubin reaching the intestines). Other symptoms can include:

  • Intense itching (pruritus), especially on palms and soles
  • Fatigue and weakness
  • Abdominal pain, particularly in the upper right quadrant
  • Nausea and vomiting
  • Loss of appetite and unintentional weight loss
  • Fever (if infection is present)
  • Confusion or altered mental state (in severe cases)

Diagnostic Tests for Elevated Direct Bilirubin

When direct bilirubin is elevated, healthcare providers typically order additional tests to determine the underlying cause. A comprehensive liver panel includes not just bilirubin levels but also liver enzymes (ALT, AST, ALP, GGT), albumin, and total protein. These markers help distinguish between hepatocellular injury (liver cell damage) and cholestatic patterns (bile flow problems).

If you're experiencing symptoms or have risk factors for liver disease, regular monitoring of your liver function biomarkers can help catch problems early. Comprehensive testing that includes direct bilirubin, liver enzymes, and other metabolic markers provides a complete picture of your liver health.

Imaging and Additional Testing

Beyond blood tests, imaging studies play a crucial role in diagnosing the cause of elevated direct bilirubin. Ultrasound is often the first imaging test, as it can detect gallstones, bile duct dilation, and liver abnormalities. CT scans or MRI/MRCP provide more detailed views of the liver, bile ducts, and surrounding structures. In some cases, endoscopic procedures like ERCP may be needed to both diagnose and treat bile duct obstructions.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Treatment Approaches for High Direct Bilirubin

Treatment for elevated direct bilirubin depends entirely on the underlying cause. Addressing the root problem is essential for normalizing bilirubin levels and preventing further liver damage.

For bile duct obstructions, treatment may involve removing gallstones through ERCP, placing stents to open narrowed ducts, or surgery for tumors. Liver diseases require specific approaches: antiviral medications for hepatitis, lifestyle modifications for fatty liver disease, immunosuppressants for autoimmune conditions, or chelation therapy for metal overload disorders.

Lifestyle Modifications and Support

Regardless of the cause, certain lifestyle changes can support liver health and help manage elevated direct bilirubin:

  • Avoid alcohol completely if you have liver disease
  • Maintain a healthy weight through balanced nutrition
  • Exercise regularly to improve metabolic health
  • Stay hydrated to support liver function
  • Avoid unnecessary medications and supplements
  • Get vaccinated against hepatitis A and B if not already immune
  • Manage underlying conditions like diabetes and high cholesterol

When to Seek Medical Attention

Certain symptoms warrant immediate medical evaluation. Seek emergency care if you experience sudden severe abdominal pain, high fever with jaundice, confusion or altered mental state, persistent vomiting, or signs of bleeding (black stools, vomiting blood). These could indicate serious complications like acute liver failure, ascending cholangitis, or variceal bleeding.

For non-emergency situations, see your healthcare provider if you notice persistent fatigue, unexplained weight loss, chronic itching, or any yellowing of skin or eyes. Early detection and treatment of liver problems can prevent progression to more serious conditions.

Monitoring and Prevention Strategies

Regular monitoring of liver function is crucial for anyone with risk factors for liver disease or a history of elevated bilirubin. This includes people with chronic viral hepatitis, excessive alcohol use, obesity, diabetes, family history of liver disease, or exposure to hepatotoxic medications or chemicals.

Prevention strategies focus on maintaining overall liver health through healthy lifestyle choices, avoiding hepatotoxic substances, managing metabolic conditions, and getting regular check-ups. If you have existing liver disease, work closely with your healthcare team to monitor progression and adjust treatment as needed.

For a comprehensive analysis of your existing blood test results, including liver function markers like direct bilirubin, you can use SiPhox Health's free upload service. This AI-driven platform provides personalized insights and actionable recommendations based on your unique health profile, helping you better understand your liver health and track changes over time.

Taking Control of Your Liver Health

Elevated direct bilirubin is a important marker that shouldn't be ignored. While it can indicate serious conditions, many causes are treatable when caught early. Understanding your bilirubin levels in the context of other liver function tests provides valuable insights into your overall health. Regular monitoring, lifestyle modifications, and appropriate medical care can help maintain healthy liver function and prevent complications. Remember that your liver has remarkable regenerative capabilities—with proper care and treatment, many liver conditions can improve significantly over time.

References

  1. Fevery J. Bilirubin in clinical practice: a review. Liver Int. 2008 May;28(5):592-605.[Link][PubMed][DOI]
  2. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of cholestatic liver diseases. J Hepatol. 2009 Aug;51(2):237-67.[Link][PubMed][DOI]
  3. Roche SP, Kobos R. Jaundice in the adult patient. Am Fam Physician. 2004 Jan 15;69(2):299-304.[Link][PubMed]
  4. Vítek L, Ostrow JD. Bilirubin chemistry and metabolism; harmful and protective aspects. Curr Pharm Des. 2009;15(25):2869-83.[Link][PubMed][DOI]
  5. Sticova E, Jirsa M. New insights in bilirubin metabolism and their clinical implications. World J Gastroenterol. 2013 Oct 14;19(38):6398-407.[Link][PubMed][DOI]
  6. Erlinger S, Arias IM, Dhumeaux D. Inherited disorders of bilirubin transport and conjugation: new insights into molecular mechanisms and consequences. Gastroenterology. 2014 Jun;146(7):1625-38.[Link][PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my direct bilirubin at home?

You can test your direct bilirubin at home with SiPhox Health's Heart & Metabolic Program or Ultimate 360 Health Program. Both CLIA-certified programs include comprehensive liver function testing with direct bilirubin, providing lab-quality results from the comfort of your home.

What is the normal range for direct bilirubin?

Normal direct bilirubin levels typically range from 0.0 to 0.3 mg/dL, representing about 20% of total bilirubin. Levels above 0.3 mg/dL are considered elevated and may indicate liver dysfunction or bile duct obstruction.

Can elevated direct bilirubin be reversed?

Yes, in many cases elevated direct bilirubin can be reversed by treating the underlying cause. Removing bile duct obstructions, treating hepatitis, stopping hepatotoxic medications, or improving liver health through lifestyle changes can normalize bilirubin levels.

What's the difference between direct and total bilirubin?

Total bilirubin includes both direct (conjugated) and indirect (unconjugated) forms. Direct bilirubin is processed by the liver and water-soluble, while indirect bilirubin hasn't been processed yet. Elevated direct bilirubin specifically indicates liver or bile duct problems.

How quickly can direct bilirubin levels change?

Direct bilirubin levels can change within hours to days depending on the cause. Acute bile duct obstruction can cause rapid rises, while chronic liver disease typically shows gradual increases. After treatment, levels may normalize within days to weeks.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details